These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1284254)

  • 1. CSF 5-HIAA as a predictor of treatment response in trichotillomania.
    Ninan PT; Rothbaum BO; Stipetic M; Lewine RJ; Risch SC
    Psychopharmacol Bull; 1992; 28(4):451-5. PubMed ID: 1284254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
    Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder.
    Hou C; Jia F; Liu Y; Li L
    Brain Res; 2006 Jun; 1095(1):154-8. PubMed ID: 16713589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF neurotransmitter metabolites and neuropsychiatric symptomatology in patients with normal pressure hydrocephalus.
    Markianos M; Lafazanos S; Koutsis G; Sfagos C; Seretis A
    Clin Neurol Neurosurg; 2009 Apr; 111(3):231-4. PubMed ID: 19046799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
    Yoshino K
    No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasma levels of MHPG, HVA and total 5-HIAA in depression. Preliminary study].
    Raucoules D; Levy C; Azorin JM; Bruno M; Valli M
    Encephale; 1992; 18(6):611-6. PubMed ID: 1285270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-rated aggression and cerebral monoaminergic turnover. Sex differences in patients with persistent depressive disorder.
    Prochazka H; Agren H
    Eur Arch Psychiatry Clin Neurosci; 2003 Aug; 253(4):185-92. PubMed ID: 12910349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
    Fujimoto A; Nagao T; Ebara T; Sato M; Otsuki S
    Biol Psychiatry; 1983 Oct; 18(10):1141-52. PubMed ID: 6197099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.
    Nilsson LK; Nordin C; Jönsson EG; Engberg G; Linderholm KR; Erhardt S
    J Psychiatr Res; 2007; 41(1-2):144-51. PubMed ID: 16434056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment.
    Stuerenburg HJ; Ganzer S; Müller-Thomsen T
    Neuro Endocrinol Lett; 2004 Dec; 25(6):435-7. PubMed ID: 15665806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder.
    Sher L; Carballo JJ; Grunebaum MF; Burke AK; Zalsman G; Huang YY; Mann JJ; Oquendo MA
    Bipolar Disord; 2006 Oct; 8(5 Pt 2):543-50. PubMed ID: 17042827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE; Foxx JL; Butler IJ
    Ann Neurol; 1980 Jul; 8(1):38-42. PubMed ID: 6157351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
    Carpenter LL; Moreno FA; Kling MA; Anderson GM; Regenold WT; Labiner DM; Price LH
    Biol Psychiatry; 2004 Sep; 56(6):418-26. PubMed ID: 15364040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical course and CSF monoamine metabolism in neuroleptic malignant syndrome--a study of nine typical cases and five mild cases].
    Nishijima K; Ishiguro T
    Seishin Shinkeigaku Zasshi; 1989; 91(6):429-56. PubMed ID: 2479043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine metabolites in cerebrospinal fluid during acute cerebral ischemia.
    Tang HZ; Lu XF; Wang KJ; Ou YS; Huang YQ
    Chin Med J (Engl); 1989 Jan; 102(1):18-23. PubMed ID: 2475306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid monoaminergic metabolites are elevated in adults with Down's syndrome.
    Kay AD; Schapiro MB; Riker AK; Haxby JV; Rapoport SI; Cutler NR
    Ann Neurol; 1987 Apr; 21(4):408-11. PubMed ID: 2437853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The changes of monoamine metabolites in CSF of patients with cerebral stroke].
    Tang HZ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Jun; 24(3):130-2, 186. PubMed ID: 1716195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age of onset of trichotillomania symptoms: investigating clinical correlates.
    Flessner CA; Lochner C; Stein DJ; Woods DW; Franklin ME; Keuthen NJ
    J Nerv Ment Dis; 2010 Dec; 198(12):896-900. PubMed ID: 21135642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid 5-hydroxyindolacetic acid correlates directly with negative affective intensity, but not affective lability, in human subjects.
    Coccaro EF; Boparai A; Lee R
    Int J Neuropsychopharmacol; 2013 Mar; 16(2):261-9. PubMed ID: 22475556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Movement decoupling: A self-help intervention for the treatment of trichotillomania.
    Moritz S; Rufer M
    J Behav Ther Exp Psychiatry; 2011 Mar; 42(1):74-80. PubMed ID: 20674888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.